readthroughSign in
CompanySRZNNasdaqSouth San Francisco, CA

Surrozen, Inc./DE

Surrozen develops Wnt-based biologics for sight-threatening ophthalmic conditions.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story